Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Paravit-CF
- Development stage
- Unknown
- Lead developer
- Nordic Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Paravit-CF is a specialist fat-soluble vitamin supplement formulated for the dietary management of individuals with cystic fibrosis, particularly those with pancreatic insufficiency or malabsorption. It is classified as a Food for Special Medical Purposes (FSMP) and is designed to reduce the medication burden by combining four essential fat-soluble vitamins—vitamin A (retinyl palmitate), vitamin D3 (cholecalciferol), vitamin E (dl-alpha tocopheryl acetate), and vitamin K1 (phytomenadione)—into a single daily dose. The formulation utilizes Medium Chain Triglyceride (MCT) absorption technology to facilitate passive absorption across the gut wall without requiring pancreatic enzymes or bile salts.
- Brand names
- Paravit-CF
- Other names
- Paravit-CF CapsulesParavit-CF Liquid
02
Targets
GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)TTPA (Alpha-tocopherol transfer protein)RXRA (Retinoid X receptor alpha)VDR (Vitamin D receptor)VKORC1 (Vitamin K epoxide reductase complex subunit 1)RAR (Retinoic acid receptor)
Beyond the preview
Go deeper on Paravit-CF.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Paravit-CF.